Reduction of metformin renal tubular secretion by cimetidine in man.

To determine whether cimetidine altered the renal handling of metformin, seven subjects took 0.25 g metformin daily with and without cimetidine 0.4 g twice daily. Blood and urine samples were collected and assayed for metformin, cimetidine and creatinine by h.p.l.c. Cimetidine significantly increased the area under the plasma metformin concentration-time curve by an average of 50% and reduced its renal clearance over 24 h by 27% (P less than 0.008). There was no alteration in the total urinary recovery of metformin when cimetidine was co-administered. The effect of cimetidine on the renal clearance of metformin was time dependent, being significantly reduced up to 6 h following cimetidine. These results appeared to be consistent with competitive inhibition of renal tubular secretion. Cimetidine had no effect on the renal clearance of creatinine, but time-dependent variations in both metformin and creatinine renal clearance were observed. Metformin had no effect on cimetidine disposition. It is concluded that cimetidine inhibits the renal tubular secretion of metformin in man, resulting in higher circulating plasma concentrations. Because of its propensity for causing dose and concentration-dependent adverse effects, the dose of metformin should be reduced when cimetidine is co-prescribed.

[1]  J. H. Sirota,et al.  Diurnal variations of renal function in man. , 1950, The Journal of clinical investigation.

[2]  Wayne W. Daniel,et al.  Biostatistics: A Foundation for Analysis in the Health Sciences , 1974 .

[3]  G. Franceschini,et al.  Disposition of metformin (N,N‐dimethylbiguanide) in man , 1978, Clinical pharmacology and therapeutics.

[4]  W. W. Daniel Applied Nonparametric Statistics , 1979 .

[5]  P. Phillips,et al.  Metformin associated lactic acidosis. , 1978, Australian and New Zealand journal of medicine.

[6]  P. Welling,et al.  Probenecid: an unexplained effect on cephalosporin pharmacology. , 1979, British journal of clinical pharmacology.

[7]  J. Siepler,et al.  Relationship between cimetidine plasma levels and gastric acidity in acutely ill patients. , 1980, American journal of hospital pharmacy.

[8]  H Connor,et al.  Metformin kinetics in healthy subjects and in patients with diabetes mellitus. , 1981, British journal of clinical pharmacology.

[9]  R. Cutler,et al.  Inhibition of renal creatinine secretion by cimetidine in humans. , 1982, Renal physiology.

[10]  K. Speeg,et al.  Cimetidine and procainamide secretion by proximal tubules in vitro. , 1982, The American journal of physiology.

[11]  M. Uusitupa,et al.  The pharmacokinetics of metformin: a comparison of the properties of a rapid-release and a sustained-release preparation. , 1983, International journal of clinical pharmacology, therapy, and toxicology.

[12]  W. L. Chiou,et al.  Creatinine XII: comparison of assays of low serum creatinine levels using high-performance liquid chromatography and two picrate methods. , 1983, Journal of pharmaceutical sciences.

[13]  D. Greenblatt,et al.  Effect of cimetidine on digoxin kinetics and creatinine clearance. , 1984, American heart journal.

[14]  K. Speeg,et al.  Cimetidine inhibits renal procainamide clearance , 1984, Clinical pharmacology and therapeutics.

[15]  A. Somogyi,et al.  Effect of cimetidine on renal and hepatic drug elimination: Studies with triamterene , 1986, Clinical pharmacology and therapeutics.

[16]  A. Somogyi,et al.  Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs. , 1986, The Journal of pharmacology and experimental therapeutics.

[17]  A. Somogyi,et al.  Rapid and sensitive high-performance liquid chromatographic assay for metformin in plasma and urine using ion-pair extraction techniques. , 1986, Journal of chromatography.